Ameritas Investment Partners, Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,673
-18.9%
8670.0%0.00%0.0%
Q2 2023$16,854
-31.5%
8670.0%0.00%0.0%
Q1 2023$24,597
-15.7%
8670.0%0.00%0.0%
Q4 2022$29,166
+32.6%
8670.0%0.00%0.0%
Q3 2022$22,000
-42.1%
8670.0%0.00%
-50.0%
Q2 2022$38,000
-11.6%
8670.0%0.00%0.0%
Q1 2022$43,000
-2.3%
8670.0%0.00%
+100.0%
Q4 2021$44,000
-8.3%
8670.0%0.00%
-50.0%
Q3 2021$48,000
+29.7%
8670.0%0.00%
+100.0%
Q2 2021$37,000
+2.8%
8670.0%0.00%0.0%
Q1 2021$36,000
-10.0%
8670.0%0.00%
-50.0%
Q4 2020$40,000
+8.1%
8670.0%0.00%0.0%
Q3 2020$37,000
-11.9%
8670.0%0.00%0.0%
Q2 2020$42,000
+5.0%
8670.0%0.00%0.0%
Q1 2020$40,000
-23.1%
8670.0%0.00%0.0%
Q4 2019$52,000
+6.1%
8670.0%0.00%0.0%
Q3 2019$49,000
+2.1%
8670.0%0.00%0.0%
Q2 2019$48,000
+9.1%
8670.0%0.00%0.0%
Q1 2019$44,000
+25.7%
8670.0%0.00%0.0%
Q4 2018$35,000
-41.7%
8670.0%0.00%
-33.3%
Q3 2018$60,000
-9.1%
8670.0%0.00%0.0%
Q2 2018$66,000
+69.2%
867
+16.1%
0.00%
+50.0%
Q1 2018$39,000
-2.5%
7470.0%0.00%0.0%
Q4 2017$40,0000.0%7470.0%0.00%0.0%
Q3 2017$40,000
-32.2%
7470.0%0.00%
-33.3%
Q2 2017$59,000
+7.3%
747
+12.8%
0.00%0.0%
Q1 2017$55,0006620.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders